05:01 AM

TransUnion Healthcare’s Insurance Discovery Solution Recognized by KLAS

TransUnion Healthcare today announced that its eScan Insurance Discovery solution was recognized by KLAS®, a global research and insights firm addressing the healthcare IT (HIT) industry, receiving an overall score of 89.4 out of 100 for Coverage Discovery in the 2018 Best in KLAS Software and Services Report.

To underscore the value of the solution, a customer recently commented to KLAS that “eScan is a mix between a technology and a service. TransUnion Healthcare patrols our admissions and catches certain payers who aren’t identified during registration...The technology is amazing.”

“The KLAS recognition demonstrates TransUnion Healthcare’s commitment to continually providing exceptional Revenue Protection™ solutions, accompanied by superior service and support, and as a result, delivering greater value to our clients,” said Gerry McCarthy, president of TransUnion Healthcare.

TransUnion Healthcare’s Revenue Protection solutions help hospitals prevent revenue leakage by engaging patients early, helping ensure their earned revenue gets paid, and optimizing their collection strategies. The company works with more than 1800 hospitals and health systems and has protected over $4.4 billion in net revenue and cash to date for its entire client base.

The eScan Insurance Discovery solution leverages patented data matching technology with hundreds of query permutations to deliver a series of automated, customizable reports that identify insurance coverage for patient accounts. TransUnion Healthcare continues to invest millions of dollars in research, development and acquisition of new data and technology to make eScan the most effective insurance discovery solution in the industry.

The information contained in the KLAS report is a compilation of data gathered from interviews with healthcare providers and represents a snapshot in time of information in the KLAS database.

KLAS is a research firm on a global mission to improve healthcare delivery by enabling provider and payer voices to be heard. By working with thousands of healthcare executives and clinicians, KLAS gathers data on software, services and medical equipment to deliver timely reports, trending data, and statistical overviews about the healthcare industry. The research directly represents the provider voice and acts as a catalyst for improving vendor performance. Founded in 1996, KLAS has been providing transparency to the healthcare industry for over 20 years.

For additional information about TransUnion Healthcare, please visit:


About TransUnion Healthcare

TransUnion Healthcare, a wholly owned subsidiary of credit and information management company TransUnion, is a trusted provider of Healthcare Revenue Protection™ solutions for maximizing reimbursement, improving patient engagement, and preventing revenue leakage. We deliver this by leveraging our data assets, market-leading revenue cycle management technologies, and deep insights into consumer financial behavior and reimbursement methodologies, to help providers reduce uncompensated care and maximize revenue with one of the most effective revenue protection solutions on the market today.

About TransUnion (NYSE: TRU)

Information is a powerful thing. At TransUnion, we realize that. We are dedicated to finding innovative ways information can be used to help individuals make better and smarter decisions. We help uncover unique stories, trends and insights behind each data point, using historical information as well as alternative data sources. This allows a variety of markets and businesses to better manage risk and consumers to better manage their credit, personal information and identity. Today, TransUnion has a global presence in more than 30 countries and a leading presence in several international markets across North America, Africa, Latin America and Asia. Through the power of information, TransUnion is working to build stronger economies and families and safer communities worldwide.

We call this Information for GoodSM.